(Q33869335)

29 July 2017

1 reference

title

Use of radionuclides for the palliation of bone metastases (English)

1 reference

29 July 2017

McEwan AJ

1

1 reference

29 July 2017

publication date

1 April 2000

1 reference

Seminars in Radiation Oncology

29 July 2017

published in

1 reference

29 July 2017

volume

10

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

103-114

1 reference

The prevalence and severity of pain in cancer

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

Presenting symptoms in patients referred to a multidisciplinary clinic for bone metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

Bone metastases: pathophysiology and management policy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

Palliative therapy with bone seeking radiopharmaceuticals

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

The role of bisphosphonates in the treatment of painful metastatic bone disease: a review of phase III trials

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

Current use of bisphosphonates in oncology. International Bone and Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

Phosphorus-32 radiopharmaceuticals for the treatment of painful osseous metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

Unsealed source therapy of painful bone metastases: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

Cancer therapy using bone-seeking isotopes.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

Tin-117m: production, chemistry and evaluation as a bone-scanning agent.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

The development and in-vivo behavior of tin containing radiopharmaceuticals--I. Chemistry, preparation, and biodistribution in small animals

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

Rhenium-186 hydroxyethylidene diphosphonate for the treatment of painful osseous metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

Malignant bone resorption: cellular and biochemical mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

A retrospective analysis of the cost effectiveness of treatment with Metastron (89Sr-chloride) in patients with prostate cancer metastatic to bone

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

Painful bone metastases in hormone-refractory prostate cancer: economic costs of strontium-89 and/or external radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

Effective and economical option for pain palliation in prostate cancer with skeletal metastases: 32P therapy revisited.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

The palliation of osseous metastasis with 32P or 89Sr compared with external beam and hemibody irradiation: a historical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

Strontium-89 chloride for pain palliation in prostatic skeletal malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

A phase I study of samarium-153 ethylenediaminetetramethylene phosphonate therapy for disseminated skeletal metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

A phase II study of treatment of painful multifocal skeletal metastases with single and repeated dose samarium-153 ethylenediaminetetramethylene phosphonate

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

Dose escalation study of rhenium-186 hydroxyethylidene diphosphonate in patients with metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

Strontium 89 therapy for the palliation of pain due to osseous metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

The final report of the expert panel for the radiation oncology bone metastasis work group of the American College of Radiology

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

Strontium-89 chloride in the treatment of bone metastases from breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

The effect of repeated strontium-89 chloride therapy on bone pain palliation in patients with skeletal cancer metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

Strontium-89 for symptomatic metastatic prostate cancer to bone: recommendations for hospice patients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

Radiosensitization with low-dose carboplatin enhances pain palliation in radioisotope therapy with strontium-89

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

Multicentre trial on the efficacy and toxicity of single-dose samarium-153-ethylene diamine tetramethylene phosphonate as a palliative treatment for painful skeletal metastases in China.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

Palliative therapy with rhenium-186-HEDP for bone metastases of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

Rhenium-186 HEDP: palliative radionuclide therapy of painful bone metastases. Preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

The palliation of symptomatic osseous metastases: final results of the Study by the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

Single-dose half-body irradiation for palliation of multiple bone metastases from solid tumors. Final Radiation Therapy Oncology Group report

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

Hematologic depression following therapy with strontium-89 chloride

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

Haemostatic pitfalls in advanced prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1053-4296%2800%2980047-8

1 reference

7 January 2021

10.1016/S1053-4296(00)80047-8

Identifiers

DOI

1 reference

29 July 2017

1 reference